First Heartland Consultants’s Opus Genetics IRD Stock Holding History

First Heartland Consultants’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-45	Closed	-$11K	–	358
2017 Q1	$11K	Hold	45	–	–	﹤0.01%	327
2016 Q4	$3K	Hold	45	–	–	﹤0.01%	323
2016 Q3	$5K	Hold	45	–	–	﹤0.01%	321
2016 Q2	$5	Hold	45	–	–	﹤0.01%	301
2016 Q1	$7K	Hold	45	–	–	﹤0.01%	271
2015 Q4	$8K	Hold	45	–	–	﹤0.01%	271
2015 Q3	$11K	Buy	45 +3	+7%	+$815	﹤0.01%	259
2015 Q2	$12	Hold	42	–	–	﹤0.01%	262
2015 Q1	$15K	Sell	42 -21	-33%	-$7.63K	0.01%	255
2014 Q4	$21K	Buy	63 +42	+200%	+$14.5K	0.01%	248
2014 Q3	$8K	Buy	+21	New	+$7.56K	﹤0.01%	249

Other funds holding IRD

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HVIA

Hudson Valley Investment Advisors Goshen, New York $823M AUM 31.4% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

First Heartland Consultants's IRD Position: Q2 2017 in Review

First Heartland Consultants sold out of Opus Genetics (IRD) in Q2 2017, closing a stake of 45 shares — an estimated $11K sold.

First Heartland Consultants first reported a position in IRD in Q3 2014 and held it in 11 quarters. The position peaked at $21K in Q4 2014. 23 funds tracked by Wall St. Rank hold IRD as of Q2 2017.

First Heartland Consultants reported no remaining Opus Genetics position as of Q2 2017 after selling out during the quarter.
First Heartland Consultants sold 45 Opus Genetics shares in Q2 2017, an estimated $11K.
First Heartland Consultants first reported a position in Opus Genetics in Q3 2014 and held it in 11 quarters.
First Heartland Consultants's Opus Genetics position peaked at $21K in Q4 2014.
23 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2017.

Based on First Heartland Consultants's 13F filing for Q2 2017, filed 26 Jul 2017.